{
    "organizations": [],
    "uuid": "b8bfc215bd71c6a4396db993e54491699e7b1bda",
    "author": "",
    "url": "https://www.reuters.com/article/brief-knight-therapeutics-says-new-drug/brief-knight-therapeutics-says-new-drug-submission-for-netildex-accepted-for-review-by-health-canada-idUSFWN1Q5168",
    "ord_in_thread": 0,
    "title": "BRIEF-Knight Therapeutics Says New Drug Submission For Netildex Accepted For Review By Health Canada​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 15, 2018 / 1:54 PM / Updated 10 minutes ago BRIEF-Knight Therapeutics Says New Drug Submission For Netildex Accepted For Review By Health Canada​ Reuters Staff Feb 15 (Reuters) - Knight Therapeutics Inc: * KNIGHT THERAPEUTICS AND SIFI S.P.A. ANNOUNCE FILING OF NEW DRUG SUBMISSION FOR NETILDEX IN CANADA * KNIGHT THERAPEUTICS INC - ‍KNIGHT‘S NEW DRUG SUBMISSION FOR NETILDEX HAS BEEN ACCEPTED FOR REVIEW BY HEALTH CANADA​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-15T15:54:00.000+02:00",
    "crawled": "2018-02-15T16:05:35.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "say",
        "new",
        "drug",
        "submission",
        "netildex",
        "accepted",
        "review",
        "health",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "knight",
        "therapeutic",
        "inc",
        "knight",
        "therapeutic",
        "sifi",
        "announce",
        "filing",
        "new",
        "drug",
        "submission",
        "netildex",
        "canada",
        "knight",
        "therapeutic",
        "inc",
        "new",
        "drug",
        "submission",
        "netildex",
        "accepted",
        "review",
        "health",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}